AwardedNetherlandsGoodsFramework agreement€600,000
Bioactief glas S53P4
- Published
- Published 27 May 2026
Overview
Academisch Ziekenhuis Maastricht has awarded a contract to Leander Healthcare B.V. for the supply of BonAlive bioactive glass type S53P4, used for treating infected bone defects in orthopedic, traumatologic, and septic surgery. The contract, valued at €100,000 per year for an initial four-year term with two optional renewal years, was awarded on 1 January 2026 and is now complete.
Key details
- Country
- Netherlands
- Status
- Awarded
- Category
- Goods
- Estimated value
- €600,000
- Procedure
- Direct
- Contract type
- Framework agreement
- Published
- 27 May 2026
Orthopaedic support devicesSurgical implants
Award outcome
- Award date
- 1 January 2026
- Contract period
- — → 11 December 2029
- Leander Healthcare B.V.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
9 July 2026
Contract Notice
27 May 2026
Contracting authority
Academisch Ziekenhuis Maastricht
Procuring entityMAASTRICHT, Netherlands
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.